About Us

Caris Life Sciences™ and Caris Diagnostics™ (a division Caris Life Sciences) are at the forefront of precision healthcare, helping patients and their physicians find the right treatment for cancer and other complex diseases. The company's four areas of focus--anatomic pathology, molecular profiling, pharmaceutical services and research and development--combine current state-of-the-art testing methodologies with emerging technologies. Caris brings better outcomes to patients today and advances the frontier of what is possible tomorrow.

Together, these four areas of focus aim to improve healthcare through innovation and quality. Precision diagnostic tests and services provide the intellectual foundation for rational treatment selection and the evolution of increasingly personalized approaches to disease management. Collectively, these trends will lower healthcare costs, focus the allocation of finite, expensive healthcare resources and, most important, improve health outcomes and quality of life for patients. These results earn Caris the privilege of serving as a trusted advisor to thousands of physicians across the country.

Formed in 1996, the company is headquartered in Dallas, Texas and operates four laboratories: Dallas, Texas; Phoenix, Arizona (2 sites) and Boston, Massachusetts.